AVGEMSI
Gemcitabine
- Strength
- 38 mg/mL
- Form
- Injection, Solution
- Class
- Nucleoside Metabolic Inhibitor
Avyxa Pharma, LLC
Not stocked by us — reference only
Listed by BluePoint Laboratories
| Dosage form | Injection, Solution |
|---|---|
| Route | Intravenous |
| Drug class | Nucleoside Metabolic Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 68001-342 |
| FDA application | NDA209604 |
| RxNorm concept | 1998783 |
| Package sizes listed | 1 |
| Marketed since | May 2018 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Gemcitabine
Avyxa Pharma, LLC
Not stocked by us — reference only
Gemcitabine
Avyxa Pharma, LLC
Not stocked by us — reference only
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Fresenius Kabi USA, LLC
Not stocked by us — reference only
GEMCITABINE HYDROCHLORIDE
Mylan Institutional LLC
Not stocked by us — reference only
Hospira, Inc.
Not stocked by us — reference only
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
GEMCITABINE HYDROCHLORIDE
Mylan Institutional LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.